Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SPL 026

Next Previous
X
Search
Drug Profile

SPL 026

Alternative Names: DMT - Cybin; N,N-dimethyltryptamine - Cybin; SPL-026

Latest Information Update: 16 Feb 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Small Pharma
  • Developer Cybin
  • Class Antidepressants; Antipsychotics; Dimethylamines; Drug withdrawal therapies; Fumarates; Neuropsychotherapeutics; Small molecules; Tryptamines; Vascular disorder therapies
  • Mechanism of Action Serotonin receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Major depressive disorder

Most Recent Events

  • 14 Feb 2024 Cybin has patent protection for formulations of certain deuterated analogs of deuterated dimethyltryptamine in Canada
  • 07 Feb 2024 Cybin has patent protection for DMT and dDMT compounds in Japan
  • 25 Oct 2023 Cybin has patent protection for Therapeutic compounds in USA (US1 177 168 1B2)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top